VisEn Medical

VisEn Medical designs, develops, and commercializes in vivo fluorescence imaging technology platforms. The company's fluorescence molecular tomography imaging systems and in vivo imaging agents deliver fluorescence molecular imaging performance for the identification, characterization, and quantification of various disease biomarkers and in vivo therapeutic effects. It also provides ReninSense 680, an imaging agent for measuring and monitoring key biomarkers of hypertension and kidney disease in vivo, as well as VivoTag 680XL fluorescent dye for labeling biomolecules in both in vitro and in vivo imaging applications. Additionally, the company offers fluorescence tomography imaging systems.